Jinjin Yu Selected Research

Jinjin Yu Research Topics

Disease

14	Neoplasms (Cancer) 05/2022 - 04/2012
10	Inflammation (Inflammations) 10/2022 - 01/2019
8	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2019 - 04/2012
6	Atherosclerosis 09/2021 - 10/2019
6	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 05/2015
3	Neoplasm Metastasis (Metastasis) 05/2022 - 05/2015
2	Rheumatoid Arthritis 08/2022 - 01/2022
2	Cardiovascular Diseases (Cardiovascular Disease) 07/2021 - 11/2017
2	Ovarian Epithelial Carcinoma 08/2020 - 01/2018
2	Endometrial Neoplasms (Endometrial Cancer) 03/2014 - 03/2014
1	Shock 10/2022
1	Carcinogenesis 05/2022
1	Hepatocellular Carcinoma (Hepatoma) 05/2022
1	Keratoconus 05/2022
1	Arthritis (Polyarthritis) 01/2022
1	Wounds and Injuries (Trauma) 01/2022
1	Acute Lung Injury 01/2022
1	Hyperlipidemias (Hyperlipidemia) 09/2021
1	Arteriosclerosis 04/2021
1	Uveitis 02/2021
1	Diverticulum 01/2021
1	Cicatrix (Scar) 01/2021
1	Melanoma (Melanoma, Malignant) 11/2020
1	Aphakia 07/2020
1	Lens Subluxation 07/2020
1	Cataract (Cataracts) 07/2020
1	Myopia 01/2020
1	Macular Edema 01/2020
1	Reperfusion Injury 01/2020
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2020
1	Adenocarcinoma of Lung 10/2019
1	Vascular Diseases (Vascular Disease) 10/2019
1	Starvation 08/2018
1	Infections 06/2018
1	Lymphatic Metastasis 01/2018
1	Breast Diseases (Breast Disease) 01/2018

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 05/2022 - 11/2017
5	Long Noncoding RNAIBA 10/2019 - 11/2015
4	Biological ProductsIBA 08/2022 - 05/2015
4	Biomarkers (Surrogate Marker)IBA 08/2020 - 01/2018
3	tectoridinIBA 10/2022 - 01/2022
3	Cyclin D1IBA 01/2019 - 03/2014
2	LipopolysaccharidesIBA 10/2022 - 01/2022
2	Messenger RNA (mRNA)IBA 05/2022 - 03/2014
2	Apolipoproteins E (ApoE)IBA 09/2021 - 04/2021
2	oxidized low density lipoproteinIBA 09/2021 - 03/2020
2	epicatechin gallateIBA 09/2021 - 01/2021
2	Polysaccharides (Glycans)IBA 04/2021 - 03/2020
2	HydrogelsIBA 02/2021 - 11/2020
2	BuforminIBA 10/2018 - 01/2018
2	CateninsIBA 02/2016 - 11/2015
2	RNA (Ribonucleic Acid)IBA 02/2016 - 03/2015
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2022
1	Inflammation MediatorsIBA 01/2022
1	schizandrinIBA 01/2022
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 09/2021
1	LipidsIBA 09/2021
1	Capsules (Microcapsules)IBA 07/2021
1	Pharmaceutical PreparationsIBA 02/2021
1	Drug CarriersIBA 02/2021
1	GlycerophosphatesIBA 02/2021
1	ChitosanIBA 02/2021
1	Ophthalmic Solutions (Eye Drops)IBA 02/2021
1	Adalimumab (Humira)FDA Link 02/2021
1	TeaIBA 01/2021
1	Tumor Biomarkers (Tumor Markers)IBA 01/2021
1	imperatorinIBA 01/2021
1	poly-N-isopropylacrylamideIBA 11/2020
1	Ribosomal Protein S6IBA 08/2020
1	Ribosomal Proteins (Ribosomal Protein)IBA 08/2020
1	Retinaldehyde (Retinal)IBA 01/2020
1	triacetyl-3-hydroxyphenyladenosineIBA 10/2019
1	rucaparibIBA 01/2019
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2019
1	pyrimidineIBA 08/2018
1	purineIBA 08/2018
1	InterferonsIBA 06/2018
1	Etoposide (VP 16)FDA LinkGeneric 01/2018
1	Glucose (Dextrose)FDA LinkGeneric 01/2018

Therapy/Procedure

4	Therapeutics 03/2020 - 12/2014
2	Drug Therapy (Chemotherapy) 01/2018 - 01/2018
1	Microspheres (Microsphere) 05/2022
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 07/2021
1	Intravitreal Injections 02/2021
1	Blood Transfusion (Blood Transfusions) 01/2021
1	Operative Time 01/2021
1	Length of Stay 01/2021
1	Curettage 01/2021
1	Uterine Artery Embolization 01/2021
1	Phototherapy (Light Therapy) 11/2020
1	Vitrectomy 07/2020
1	Refractive Surgical Procedures 07/2020
1	Lasers (Laser) 07/2020
1	Phacoemulsification 07/2020
1	Lenses 01/2020
1	Hysterectomy 01/2019
1	Lymph Node Excision (Lymph Node Dissection) 01/2019
1	Aftercare (After-Treatment) 01/2019
1	Radiotherapy 01/2019